What should I Know Regarding Pregnancy, Nursing and Administering Tenofovir Disoproxil Fumarate 40 Mg/Scoop (40 Mg/Gram) Oral Powder to Children or the Elderly?

If you are PREGNANT

  • FDB Only When Necessary: AVAILABLE HUMAN DATA SHOW NO INCREASED RISK FOR MAJOR BIRTH DEFECTS

If you are NURSING

  • Precaution: LIMITED DATA SUGGEST NO KNOWN ADVERSE EFFECTS IN NURSING INFANT

If you are an adult over 60

  • management or monitoring precaution: Renal-Adjust dosing interval for CrCL<50mL/min. Fixed dose combinations containing tenofovir are not appropriate if dose adjustment is required. Musculoskeletal-Decreases in bone mineral density have been observed. Consider calcium and vitamin D3 supplementation.

Giving Tenofovir Disoproxil Fumarate 40 Mg/Scoop (40 Mg/Gram) Oral Powder to a child under 12

  • management or monitoring precaution: Safety and efficacy not established age < 2 years. Potential risk of osteomalacia.
  • management or monitoring precaution: Potential risk of decreased bone mineral density. Unknown effects on long-term bone health. Assess bone density with history of fractures or underlying bone loss.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.